Pathogenic Gut Flora in Patients With Chronic Heart Failure

JACC: Heart Failure

Volumn 4, Issue 3, 2016, Pages 220-227

  Pasini, Evasio ^a   Aquilani, Roberto ^b   Testa, Cristian ^c   Baiardi, Paola ^a   Angioletti, Stefania ^c   Boschi, Federica ^b   Verri, Manuela ^b   Dioguardi, Francesco ^d  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c ASST Papa Giovanni XXIII   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic heart failure; Gut flora; Inflammation; Intestinal permeability

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CELLOBIOSE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; CAMPYLOBACTER; CANDIDA; CARDIAC PATIENT; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FECES ANALYSIS; FEMALE; FUNGUS GROWTH; HEART FAILURE; HEART RIGHT ATRIUM PRESSURE; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; SALMONELLA; SHIGELLA; VENOUS BLOOD; VENOUS CONGESTION; YERSINIA ENTEROCOLITICA; CASE CONTROL STUDY; CHRONIC DISEASE; FECES; GASTROENTERITIS; GASTROINTESTINAL TRACT; HYPEREMIA; INTESTINE ABSORPTION; METABOLISM; MICROBIOLOGY; PERMEABILITY; PHYSIOLOGY;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELLOBIOSE; CHRONIC DISEASE; FECES; FEMALE; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HEART FAILURE; HUMANS; HYPEREMIA; INTESTINAL ABSORPTION; MALE; PERMEABILITY;

EID: 84959082239     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.10.009     Document Type: Article

References (39)

1. Levine B., Kalman J., Mayer L., Fillit H.M., Paker M. Elevated circulation levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
2. Sandek A., Rauchhaus M., Anker D.S., von Haehling S. The merging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care 2008, 11:632-639.
3. Sandek A., Bauditz J., Swidsinski A., et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007, 50:1561-1569.
4. Sandek A., Bjarnason I., Volk H.D., et al. Studies on bacteria endotoxin and intestinal absorption function in patient with chronic heart failure. Intern J Cardiol 2012, 157:80-85.
5. Opasich C., Rapezzi C., Lucci D., et al. Precipitating factor and decision-making processes of short-term worsening heart failure despite optimal treatment. Am J Cardio 2001, 88:382-387.
6. Fonarow G.C., Abraham W.T., Albert N.M., et al. Factors identified as precipitating hospital admission for heart failure and clinical outcomes: finding from OPTIMIZE-HF. Arch Intern Med 2008, 168:847-854.
7. Marshall B.M., Levy S.B. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev 2011, 24:718-733.
8. Aquilani R., Tramarin R., Pedretti R.F., et al. Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease. Eur Heart J 1999, 20:1020-1029.
9. Manual of Clinical Microbiology 2003, American Society for Microbiology, Washington, DC. 8th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
10. Strobel S., Brydon W.G., Ferguson A. Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of jejunum. Gut 1984, 84:1241-1246.
11. Patterson E., Cryan J.F., Fitzgerald G.F., et al. Gut microbiota, the pharmabiotics they produce and host health. Patterson E Proc Nutr Soc 2014, 73:477-489.
12. Btaiche I.F., Chan L.N., Pleva M., et al. Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients. Nutr Clin Pract 2010, 25:32-49.
13. Fruhwald S., Holzer P., Metzler H. Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact. Intensive Care Med 2007, 33:36-44.
14. Ralls M.W., Miyasaka E., Teitelbaum D.H. Intestinal microbial diversity and perioperative complications. J Parenter Enteral Nutr 2014, 38:392-399.
15. Akindipe O.A., Faul J.L., Vierra M.A., et al. The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest 2000, 117:907-910.
16. Parris C.R. The clinician's guide to short bowel syndrome. Pract Gastroenterol 2005, 29:67-106.
17. Quigley E.M., Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006, 130(2 suppl 1):S78-S90.
18. Miyasaka E.A., Feng Y., Poroyko V., et al. Total parenteral nutrition-associated lamina propria inflammation in mice is mediated by a MyD88-dependent mechanism. J Immunol 2013, 190:6607-6615.
19. Yang H., Feng Y., Sun X., Teitelbaum D.H. Enteral versus parenteral nutrition: effect on intestinal barrier function. Ann N Y Acad Sci 2009, 1165:338-346.
20. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137:1716-1724.
21. Goldszmid R.S., Trinchieri G. The price of immunity. Nat Immunol 2012, 13:932-938.
22. Stephenson H.N., John C.M., Naz N., et al. Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation. J Biol Chem 2013, 288:19661-19672.
23. Giogha C., Lung T.W., Pearson J.S., Hartland E.L. Inhibition of death receptor signaling by bacterial gut pathogens. Cytokine Growth Factor Rev 2014, 25:235-243.
24. Dhar M.S., Virdi J.S. Strategies used by Yersinia enterocolitica to evade killing by the host: thinking beyond Yops. Microbes Infect 2014, 16:87-95.
25. Shivaprakasha S., Radhakrishnan K., Karim P.M. Candida spp. other than Candida albicans: a major cause of fungaemia in a tertiary care centre. Indian J Med Microbiol 2007, 25:405-407.
26. Arutyunov G.P., Kostyukevich O.I., Serov R.A., Rylova N.V., Bylova N.A. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure. Int J Cardiol 2008, 125:240-245.
27. Pathan N., Franklin J.L., Eleftherohorinou H., et al. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase. Crit Care Med 2011, 39:1692-1711.
28. McClave S.A., Martindale R., Taylor B., et al. Appropriate use of parenteral nutrition through the perioperative period. J Parenter Enteral Nutr 2013, 37(suppl 1):99s-105s.
29. Holly N.S., John C.M., Naz N., et al. Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human toll-like receptor 4 activation. J Biol Chem 2003, 288:19661-19672.
30. Gibson G.R., Macfarlane G.T., Cummings J.H. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut 1993, 34:437-439.
31. Bohm M., Siwiec R.M., Wo J.M. Diagnosis and management of small intestinal bacterial overgrowth. Nutr Clin Pract 2013, 28:289-299.
32. Sundaram A., Koutkia P., Apovian C.M. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol 2002, 34:207-220.
33. Wilson W.H., Hazen T., Hazen S. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 2014, 124:4204-4211.
34. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
35. Salminen M.K., Rautelin H., Tynkkynen S., et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. Rhamnosus GG. Clin Infect Dis 2004, 38:62-69.
36. Cassone M., Serra P., Mondello F., et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 2003, 41:5340-5343.
37. Besselink M.G., van Santvoort H.C., Buskens E., et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial. Lancet 2008, 371:651-659.
38. Schneider S.M., Girard-Pipau F., Anty R., et al. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin Nutr 2006, 25:82-90.
39. Alverdy J., Gilbert J., DeFazio J.R. Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health. J Parenter Enteral Nutr 2014, 38:167-178.